 The name Gimoti pronounced jye-MOH-tee was developed in compliance with FDAs Guidance for Industry, Contents of a Complete Submission for the Evaluation of Proprietary Names. Based on the development program, which included research with physicians and pharmacists, as well as an international name assessment, the Company believes Gimoti is a proprietary name with strong marketing potential that is also consistent with FDAs goal of preventing medication errors and potential harm to the public by ensuring that only appropriate proprietary names are approved for use. 